INOD beats Q2 estimates, raises 2025 outlook, and eyes major AI gains with strong momentum and a 72% price upside.

The new rating is a sign the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria.

Colliers International saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 94 the day before.